Sanara MedTech (SMTI) Insider Trading & Ownership $26.79 +0.41 (+1.55%) As of 12:05 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Sanara MedTech (NASDAQ:SMTI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage42.60%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$60.89K Get SMTI Insider Trade Alerts Want to know when executives and insiders are buying or selling Sanara MedTech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SMTI Insider Buying and Selling by Quarter Sanara MedTech Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/8/2022Zachary B FlemingCEOSell417$33.00$13,761.00 11/4/2022Zachary B FlemingCEOSell563$33.00$18,579.00 11/2/2022Zachary B FlemingCEOSell20$33.02$660.40 9/22/2022Shawn M BowmanInsiderSell1,000$27.89$27,890.00 (Data available from 1/1/2013 forward) SMTI Insider Trading Activity - Frequently Asked Questions Who is on Sanara MedTech's Insider Roster? The list of insiders at Sanara MedTech includes Shawn M Bowman, and Zachary B Fleming. Learn more on insiders at SMTI. What percentage of Sanara MedTech stock is owned by insiders? 42.60% of Sanara MedTech stock is owned by insiders. Learn more on SMTI's insider holdings. Sanara MedTech Key ExecutivesMr. Ronald T. Nixon (Age 68)Executive Chairman & CEO Compensation: $100kMr. Michael D. McNeil (Age 59)CFO & Corporate Secretary Compensation: $331.1kMr. Jacob A. WaldropChief Operating OfficerMr. Bill FitzgeraldChief Compliance OfficerMs. Tricia MattesonVice President of MarketingMr. Tyler PalmerChief Corporate Development & Strategy OfficerDr. Christopher A. Morrison FACHM (Age 54)FAPWCA, FCCWS, M.D., President of Telehealth Services Compensation: $156kDr. Rebecca Erin Mcmahon (Age 39)President of Research & Development Mr. Seth YonPresident of CommercialMr. Callon NicholsVice President of Corporate Operations More Insider Trading Tools from MarketBeat Related Companies MiMedx Group Insider Buying iRadimed Insider Buying SiBone Insider Buying Semler Scientific Insider Buying Embecta Insider Buying CeriBell Insider Buying Bioventus Insider Buying Beta Bionics Insider Buying Avanos Medical Insider Buying AxoGen Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:SMTI) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanara MedTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
